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Functional divergencea b s t r a c t
Gene duplication provides genetic material required for functional diversiﬁcation. An interesting
example is the amyloid precursor protein (APP) protein family. The APP gene family has experienced
both expansion and contraction during evolution. The three mammalian members have been stud-
ied quite extensively in combined knock out models. The underlying assumption is that APP, amy-
loid precursor like protein 1 and 2 (APLP1, APLP2) are functionally redundant. This assumption is
primarily supported by the similarities in biochemical processing of APP and APLPs and on the fact
that the different APP genes appear to genetically interact at the level of the phenotype in combined
knockout mice. However, unique features in each member of the APP family possibly contribute to
speciﬁcation of their function. In the current review, we discuss the evolution and the biology of the
APP protein family with special attention to the distinct properties of each homologue. We propose
that the functions of APP, APLP1 and APLP2 have diverged after duplication to contribute distinctly
to different neuronal events. Our analysis reveals that APLP2 is signiﬁcantly diverged from APP and
APLP1.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Amyloid b peptide is the main constituent of the amyloid pla-
ques in Alzheimer patients. Amyloid precursor protein (APP) is
the precursor protein from which the Ab peptide is generated. This
peptide is produced by endoproteolytic cleavages of APP, which in
addition shed a larger soluble ectodomain in the extracellular envi-
ronment and an intracellular domain into the cytoplasm [1,2]. The
proteolytic processing of APP is a constitutive process, and explains
in part the relative short half life (less than an hour) of full length
APP [3]. Unbalanced proteolytic cleavage of APP or mutations in
the Ab sequence can result in increased production, and mainly
in alterations of the biophysical properties of Ab. Consequently,oligomerization and aggregation of Ab can contribute to the brain
pathology and neurodegeneration in familial and sporadic Alzhei-
mer Disease [2]. In contrast, our knowledge of the physiological
function of APP remains surprisingly incomplete. Although the loss
of APP and its homologues were studied in several model organ-
isms, no clear picture has yet emerged. Sometimes, the protein is
called ‘‘All Purpose Protein’’ to indicate the many different signal-
ing pathways and protein interactions in which APP has been
implicated. The different proposed functions for APP are not al-
ways consistent. For instance both enhancement and inhibition
of dendritic spine formation [4–6] or neuronal cell migration
[7,8] have been proposed to be mediated by APP.
Next to APP, APP-like proteins are present in different species.
Similar to APP, APP-like proteins (APLP) undergo proteolytic pro-
cessing [9]. Furthermore, mutant mice lacking Aplp2 combined
with App or Aplp1 display a lethal phenotype, with mice dying
around birth [10]. The genetic interactions of the App and App-like
genes and the similarity in proteolytic processing have been taken
as evidence for functional redundancy of the three App paralogues.
Therefore, experiments to deduce the biological function of APP are
mainly based on the ‘‘redundancy model’’ which assumes that the
App paralogues are functionally interchangeable. Such an approach
pays too little attention to the unique properties of each App para-
logue and might disregard the possibility that they are operating in
different and independent pathways. In such a view, their com-
bined mutations lead to a ‘’synthetic phenotype’’ (lethality) by
Table 1
The species and protein sequences used for functional divergence analysis.
Organism Accession number Gene name
Homo sapiens (Human) NP_000475.1 APP
NP_001019978.1 APLP1
NP_001135748.1 APLP2
Pan troglodytes (Chimps) NP_001013036.1 APP
XP_003316372.1 APLP1
XP_001155401.1 APLP2
Canis lupus familiaris (Dog) NP_001006601.1 APP
XP_533688.4 APLP1
XP_536530.2 APLP2
Mus musculus (Mouse) NP_001185752.1 APP
NP_031493.2 APLP1
NP_001095925.1 APLP2
Gallus gallus (Chicken) NP_989639.1 APP
NP_001006317.2 APLP2
Danio rerio (Fish) NP_571639.1 APPa
NP_690842.1 APPb
XP_001342921.4 APLP
NP_690842.1 APLP2
Xenopus laevis (Frog) NP_001082098.1 APP
NP_001089419.1 APLP1
NP_001094408.2 APLP2a
NP_001094407.1 APLP2b
Drosophila melanogaster (Fly) NP_001245451.1 APPL
Caenorhabditis elegans (Worm) NP_508871.1 APL1
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are not simply extra copies but have evolved to perform special-
ized function.
We structure our review on the divergence of APP function by
asking following questions: What are the possible evolutionary
fates of duplicated APP homologues? What does the loss of func-
tion studies tell us about the specialization of APP family proteins?
What are the similarities and differences in processing of APP and
APLPs? How does transcriptional and interaction network diver-
gences contribute to the evolution of the APP family? Finally, we
provide support for the ‘‘divergence’’ idea by using a computa-
tional method to predict critical amino acid and sub-domains that
potentially contribute to the divergence of the APP protein family.
Based on this comparison, it will become clear that the different
APP genes do not simply encode duplicated proteins with inter-
changeable function. This should bring the focus back on the un-
ique properties of each member of the APP family and might
help to explain some of the discrepancies in the ﬁeld.Fig. 1. A simpliﬁed dendrogram based on APP protein family tree of Ensemble illustra
contraction nodes are color coded. The lengths of the lines are not proportional to the evo
For details of APP protein family evolution see the text. Mya: million years ago.2. The APP family
Genes encoding for the APP protein family have experienced
several twists and turns during evolution (Table 1 lists all the spe-
cies and proteins discussed in this review). APP-like proteins have
not been identiﬁed in prokaryotes, yeasts and plants (Fig. 1). The
simplest and earliest branches of the evolutionary tree in which
APP-like genes have been identiﬁed contain insects such as the
fruit ﬂy (Drosophila melanogaster) and roundworms (Caenorhabditis
elegans) each carrying one gene encoding for an APP-like protein. It
is intriguing that APP-like proteins ﬁrst emerge in Bilaterians with
an early nervous system with functional synapses [11,12]. Indeed,
the extracellular domains of APP molecules have cell adhesion
properties and can promote cell-cell adhesion [13]. Such intercel-
lular interaction is important in early evolution for the generation
of the synaptic junction [12,14]. Strikingly, when overexpressed in
HEK cells, APP can potently induce synaptogenesis in the contact-
ing axon and this activity requires the extracellular domain as well
as the intracellular part of APP. The later associates with presynap-
tic molecules such as APP binding family A (APBA1) and Calcium/
calmodulin-dependent serine protein kinase (CASK) [15]. Interest-
ingly, APP is required both at pre- and postsynaptic compartments
to induce synaptogenesis [15] which suggests that ancestral APP
indeed might be a transmembrane protein responsible for homo-
philic interactions at the synaptic junction early in evolution.
Five nodes of duplications are observed in the phylogenetic
tree of the APP protein family when using Ensemble comparative
genomics tools (schematically represented in Fig. 1). For example,
ﬁshes (Danio rerio) have in total four genes encoding APP pro-
teins: two homologues for the human APP gene (appa and appb)
plus aplp1 and aplp2 (Fig. 1). Similar to ﬁshes, amphibians (Xeno-
pus laevis) carry four app genes in their genome but they have
two homologues for the human APLP2 gene: aplp2a, aplp2b plus
app and aplp1 (Fig. 1). Instead, birds (Gallus gallus) have lost the
APLP1 gene leaving them with APP and APLP2 genes (Fig. 1). The
paradoxical expansion and contraction of the APP family suggest
that the duplications of the encoding genes have been the subject
of highly selective evolutionary forces. The complicated trajectory
of the evolution of the APP protein family ends with the three
best-studied members in mammals: APP, APLP1 and APLP2
(Fig. 1) [16].
The evolutionary maintenance of a duplicated gene in the gen-
ome is inﬂuenced by the accumulation of genetic mutations affect-
ing the function of the descendant duplicates. Three possibletes the important events in the evolution of APP gene family. The duplication and
lutionary distance of species. The scientiﬁc names of species are listed in the Table 1.
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tion, neo(sub)functionalization or increased gene dosage [17].
The non-functionalization scenario is the result of the accumula-
tion of deleterious mutations leading to pseudogenization [18].
In case of neo-functionalization, mutations confer new features
to the duplicate which leads to the acquisition of new functions
distinct from the ancestral ones [19]. Sub-functionalization is a
modiﬁed version of neo-functionalization in which the function
of the ancestral gene becomes subdivided into sub-functions for
each duplicate providing cells with proteins with more specialized
functions [17]. Finally without any functional innovation, duplica-
tion can provide cells with genetic robustness and redundancy by
increasing the gene dosage for dosage sensitive genes [20].
Which model of gene duplication and evolution can be applied
to the APP family? While the prevalent vision stresses the ‘‘in-
creased gene dosage’’, more in depth interpretation of the data pro-
vide supporting evidence for neo- or sub-functionalization of APP
and APLPs as well. It should be noted that differential splicing of
APP can contribute to functional diversity as well by for example
changing the adhesion properties of APP or APLPs [21]. Discussion
on the role of alternative splicing in the functional divergence of
the APP protein family is however beyond the scope of this review.
3. Various roles of the APP members in the nervous system of
different species
Loss of function studies are still the standard approach to de-
duce the physiological role of a gene. The APP family has been cov-
ered rather well in that regard with gene inactivation or knock outs
(ko) in D. melanogaster, C. elegans and several combinations of gene
ko in Mus musculus. The data are somewhat divergent, but overall
they suggest strongly a role for the APP family in the central ner-
vous system.
3.1. The importance of the extracellular APP domain in the
development of C. elegans
In C. elegans, a single gene encodes for a member of the APP fam-
ily which is called apl-1. The encoded protein is very similar to the
mammalian counterpart with a large extracellular and a small
intracellular domain, while the Ab sequence as such is lacking in
APL-1 [22]. Loss of APL-1 leads to a molting defect resulting in
developmental lethality [23]. In addition, the apl-1 null mutant
worms are hypersensitive to the acetylcholinesterase inhibitor
aldicarb supporting a role for APL-1 protein at the synaptic junc-
tions [24]. Many reports stress the importance of the conserved
intracellular domains of the APP family for its function, but, unex-
pectedly, the conserved carboxyl terminus fragment of APL-1 is not
involved in the phenotype as demonstrated by rescuing the lethal-
ity of the apl-1 null mutant by the c-terminus truncated version of
APL-1 [23]. In contrast, the extracellular domain of APL-1 is sufﬁ-
cient to rescue both the lethality and hypersensitivity phenotypes.
As this domain is soluble, these data suggest a receptor for APL-1
ectodomain, and indicate the importance of this domain in
development.
3.2. The single Appl gene in D. melanogaster is involved in axonal
wiring and synaptic function
Like C. elegans, D. melanogaster also carries one homologue for
the APP gene that is called Appl. Appl expression is ﬁrst seen in
developing neurons during axogenesis [25]. Flies with an Appl null
mutation are viable and fertile, but show subtle phenotypes. For
instance at the neuromuscular junction Appl null mutant ﬂies have
a reduced number of neuromuscular buttons, whereas larvaeoverexpressing APPL show an increased number of buttons [26].
Interestingly, Torroja et al. showed that APPL is transported to syn-
aptic buttons and a highly conserved cytoplasmic YENPTY motif of
APPL is required for promoting synapse formation [26]. This synap-
togenic property might be mediated through interaction of Fasci-
clin II with APPL, while APPL is binding via its conserved
cytoplasmic domain to dX11/Mint at the synapse [27]. APPL has
also been implicated in regulation of neurite arborization [28].
Leyssen et al [28] showed that both APPL and its human homo-
logue APP can promote post-developmental neurite arborization.
Similar to its synaptogenic role, APPL requires the conserved cyto-
plasmic YENPTY for its effects on neurite arborization, but this time
the signal is transduced through the Abelson tyrosine kinase (Abl)
pathway [28]. These data suggest a role for APP in the structural
plasticity of neurons, whereas in pathological conditions such as
brain injury, APPL might promote neurite arborization [28]. Re-
cently, loss of APPL was shown to induce a developmental defect
in axonal outgrowth in mushroom bodies, a D. melanogaster center
for learning and memory. Heterozygosity for Abl kinase signiﬁ-
cantly enhanced the axonal phenotype of Appl mutant ﬂies. Mech-
anistically, APPL turned out to interact with core components of
the planar polarity pathway (PCP) mediating the Wingless-type
MMTV integration site family, member 5A (WNT5a) induced phos-
phorylation of Disheveled. Thus, it was suggested that modulation
of the PCP pathway by neuronal APPL might regulate developmen-
tal axonal wiring in mushroom bodies [29]. Overall, the loss of
function experiments in ﬂies and worms suggest that the ancestral
App-like gene has evolved to serve in the nervous system, in partic-
ular in axonal outgrowth and synapse formation. While the Dro-
sophila counterpart is really a nervous system protein, the
situation in worms is not completely clear. Absence of APL-1 re-
sults in multiple developmental defects, for instance decreased
body size and egg-laying rate [30]. It is uncertain whether these
phenotypes are the result of defects in the neuronal system or indi-
cate that APL-1 also operates in other cells, and that its function is
therefore cellular context-dependent.
3.3. The APP family in M. musculus
The situation in mammals is even more complex. The different
functions proposed for APP and its paralogues, are not converging
to a concrete model for APP family function. The single App KO
mice are viable but show various subtle phenotypes such as 15–
20% reduced body weight, disturbed forelimb strength and reduced
locomotor activity [31]. The interpretation that App ko mice show
subtle phenotypes because of compensation by other App mem-
bers, is not supported by expression studies of the other members
of the App family: compensatory up-regulation of Aplp1 and Aplp2
were not observed in these mice [31].
The alterations in muscular strength and decreased locomotor
activity in the App null mutant mice might reﬂect the synaptic role
of App in the central nervous system. Immunocytochemical analy-
sis of App null mice revealed age-dependent reduced staining for
synaptic markers such as synaptophysin, synapsin and microtu-
bule-associated protein 2 (MAP2) and increased glial ﬁbrillary
acidic protein (Gfap) immunoreactivity indicating gliosis [32]. In
addition, the mice showed impaired long term potentiation (LTP)
recordings which was highly correlated with gliosis [32]. Consis-
tent with a defect in LTP, App null mutants mice spend more time
ﬁnding the hidden platform in the Morris water maze test [32] fur-
ther suggesting a role for App in spatial learning. The defect in LTP
was associated with attenuation of GABA-mediated inhibitory
post-synaptic currents [33]. Increased expression of calcium chan-
nel, Cav1.2, was suggested as a potential mechanism regulating
GABAergic synaptic activity in inhibitory neurons [34]. Further
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excitatory vs. inhibitory neurons.
Mixed results were obtained on the role of APP in the formation
of dendritic spines [5,6,35]. Bitnner et al [6] used in vivo two pho-
ton imaging to show that c-secretase inhibition reduced spine den-
sity in an APP dependent manner. c-secretase is one of the
proteases that mediate the second cleavage of APP after ﬁrst cleav-
age by a or b-secretase (for a review see [2]). In their study layer III
and Layer V cortical neurons of App ko mice showed a two fold in-
crease in the number of dendritic spines [6]. In contrast, Lee et al.
[5] used primary rat hippocampal neurons to show that down-reg-
ulation of App decreases the number of spines, whereas over-
expression of App had the opposite effect. App needs both its
extracellular and intracellular domains to mediate these effects.
Golgi staining of spines of CA1 pyramidal neurons and layer II/III
cortical neurons revealed a signiﬁcant decrease in density and
length of spines in App null mutants [5]. More recently, Tyan
et al. [4] reported decreased spine density in primary neuronal cul-
ture of App null mutant mice conﬁrming further the role of App in
promoting spine formation. The discrepancies may arise from dif-
ferent methodologies used to image the spines (Golgi staining vs.
in vivo two photon imaging) or analyzing different types of neu-
rons, i.e., deep layer vs. upper layer pyramidal neurons of cortex
or CA1 neurons of hippocampus. One can speculate that the effect
of App is cell type speciﬁc and age dependent, which remains intel-
lectually an unsatisfying explanation, as it brings little insight into
the real function of App. It is interesting however that the role of
App in the regulation of neurite formation is reminiscent of the
role of D. melanogaster APPL in the arborization of neurites. Clearly,
there is some conservation of this role in evolution [28,29].
If App-like proteins are functionally redundant, one would ex-
pect that Aplp1 or Aplp2 ko mice would display similar phenotypes
as the App knock out. Although bothmice are much less extensively
analyzed than the App knock out, several features of their pheno-
types do not overlap [10]. Aplp1 komice appear normal both in fore-
limb strength and in reduced locomotor activity [10]. Similar,
analysis of dendritic spines of Aplp2 null mutant neurons did not re-
veal alterationsof spines in thosemice [36]. Averydifferent example
of non-conserved function is the feroxidase activity in APP which is
mediated by the REXXEmotif in the extracellular domain of APP and
is not found in APLP1 and APLP2 [37]. Thus, although furtherwork is
needed, the different phenotypes of the single ko mice support the
idea that App is specialized in its functions at the synaptic junction,
which are likely not fully compensated by Aplp1 and Aplp2. Lack of
overtphenotypes inAplp1andAplp2 singleKOmicedoesnot exclude
phenotypes that have escaped scrutiny at this moment.
Combinations of the genetic deletions of App/Aplps have been
generated [10,38]. Expression of Aplp2 alone is sufﬁcient for sur-
vival of the mice meaning that double deletion of App and Aplp1
is viable. However, in the absence of Aplp2, mice can survive only
if they express both App and Aplp1. The viability of Aplp2 single
ko might indicate that App and Aplp1 can work together to com-
pensate for a function that is dominated by Aplp2. At ﬁrst glance,
compensation by App/Aplp1 together for Aplp2 deﬁciency is a pos-
sibility, however, no compensatory up-regulation of App or Aplp1
was detected after deletion of Aplp2 [10,39]. Alternatively, it is
equally possible that App family independent mechanisms are
compensating for the lack of Aplp2. It is noteworthy that combina-
tion of Aplp1 ko with App ko or with Aplp2 ko leads to different out-
comes (survival or lethality respectively) showing speciﬁcity in the
function of App and Aplp2 [10].
Several studies support a role for App at the neuromuscular
junction. A phenotype emerges only when App deletion is analyzed
in an Aplp2 ko background (App/Aplp2 double knockout (dko)).
These mice show reduced vesicle density in the presynaptic active
zone, excessive nerve terminal sprouting and aberrant appositionof presynaptic and postsynaptic markers indicating a key role for
App in the proper formation of synaptic structures at the neuro-
muscular junction [40,41]. Interestingly, proper development of
the neuromuscular junction requires App and Aplp2 in the presyn-
aptic motor neurons and the post-synaptic muscles suggesting a
transynaptic homophilic or heterophilic interaction between App
and Aplp2 [15]. In contrast to the prominent role for soluble APP
in C. elegans, expression of soluble APP b (sAPPb) in the App/Aplp2
dko mice (App/Aplp2 sAPPbki/ki) did not rescue the lethality or neu-
romuscular defects of App/Aplp2 dko mice [42]. Strikingly, expres-
sion of soluble APP a (sAPPa) rescued the lethality of the App/Aplp2
dko mice (App/Aplp2 sAPPaki/ki) [43] indicating that a few amino
acid between a and b cleavage are instrumental in the biological
function of sAPP. How only a few amino acid residues at the carb-
oxyterminus of APPs make such a difference needs clearly further
investigation. However, App/Aplp2 sAPPaki/ki showed a widened
end plate, impaired neuromuscular transmitter release, and struc-
tural abnormalities at the neuromuscular synapses correlating
with decreased grip strength. In the central nervous system, the
mice showed impaired LTP accompanied with impaired spatial
memory [43]. Thus, sAPPawas not able to rescue several neurolog-
ical phenotypes, implying that full length APP is needed. Interest-
ingly, App/Aplp2 sAPPaki/ki mice did not have any spine or
morphological defects in cortical or hippocampal neurons.
It is very likely that thedevelopmental functionof Appat theneu-
romuscular junction is mediated through its highly conserved
YENPTY motif in its carboxyl terminus domain. App knock in mice
with a single Tyr(682) to Gly(682), Y682G,mutation (APPY682G/Y682G)
in an Aplp2 null background, display lethality and neuromuscular
defects similar to App/Aplp2 dko mice [44]. This conserved
Tyr(682) residue is both a docking site for several cytoplasmic part-
ners and a regulator of APP processing. For example, a signiﬁcant 15
fold increase in sAPP-a production together with a 3.5 fold decrease
in sAPP-b was detected in brain tissue from APPY682G/Y682G mice,
highlighting the importance of this residue in regulating APP pro-
cessing [45]. NGF-TrkA signalingwas proposed to regulate the phos-
phorylationof Tyr(682)ofAPP. TyrosinephosphorylationofAppwas
induced after NGF treatment of primary hippocampal neurons. The
tyrosine kinase activity of TrkA receptor may mediate the NGF in-
duced tyrosine phosphorylation of App [46]. It was further shown
that Y682G mutant neurons are insensitive to trophic activity of
NGF, suggesting that phosphorylation of Tyr(682) can work down-
stream of NGF-TrkA signaling to mediate the trophic effect of NGF.
A nearby conserved phosphorylated Thr(668), part of a pSer/Thr-
Pro motif, is a docking site for Pin1 and this interaction can down
regulate production of Ab peptide from APP [47]. Pin1 is a unique
peptidyl–prolyl cis/trans isomerase that can catalyze cis/trans isom-
erization of pSer/Thr-Pro motifs [48]. Binding of Pin1 to the pThr
668-Pro motif in the c-terminus of APP was shown to accelerate its
isomerization leading to conformational changes in the c-terminus
of APP [49]. In contrast to the instrumental role of Tyr(682) for sur-
vival of the mice during development, mutation in Thr(668) of APP
(T668A) in anAplp2null background, does not cause lethality or neu-
romuscular defects [50] highlighting further the importance of tyro-
sine phosphorylation of APP during development.
The fact that several App loss of function phenotypes emerge in
an Aplp2 null background is evidence for genetic interaction but
does not directly address the question whether this reﬂects really
functional redundancy between these two paralogues. Further
thorough analyses of the single mutant mice should be more infor-
mative to identify pathways in which the speciﬁc effects of Aplps
knock out become apparent. Indeed the question remains whether
double mutants generate more severe phenotypes either because
of complete loss of a redundant function or because of disruption
of multiple independent pathways leading to similar phenotypes.
For example, transcriptional proﬁling of the App and Aplp2 single
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that are up or down regulated after deletion of Aplp2, only 181
are also found altered in App mutant mice [39,51]. For instance,
signalling molecules that regulate early response to synaptic activ-
ity such as member 6 (KCNH6) (Erg2), FBJ murine osteosarcoma
viral oncogene homolog (FOS) and member 1, activity-regulated
cytoskeleton-associated protein (Arc) are signiﬁcantly down-regu-
lated in App mutant mice, but not in Aplp2 mutant mice, strength-
ening the evidence for App function in synaptic plasticity. P21 is an
example of a protein that is down regulated in both App and Aplp2
ko mice cortices. P21 is a cyclin-dependent kinase inhibitor that
regulates cell-cycle progression during G1 phase. Deﬁciency of
p21 decreases cell cycle exit and enhances proliferation of neural
stem cells by regulating the expression of pluripotency factor
Sox2 [52,53]. Thus, down-regulation of p21 in both App and Aplp2
null mutants may enhance the proliferation of neural stem cells.
This is consistent with data from Lopez-Sanchez et al. [54] demon-
strating that Aplp2 transcripts are predominantly enriched in the
proliferative zone of the developing cortex while App shows a par-
tial overlapping expression with Aplp2 in this area. Aplp2 appears
indeed to play a central role in promoting cell cycle exit during
developmental neurogenesis in the ventricular zone, and this func-
tion is likely shared with App [55]. Soluble fragments of APP and
APLP2, also, can promote proliferation of Egf expressing progeni-
tors in the subventricular zone [56]. Thus, overall it appears that
App and Aplp2 indeed are partially redundant in neurogenic
niches. Nevertheless, it should be stressed that signiﬁcant differ-
ences in the transcriptional response of App or Aplp2 deletion sug-
gest that there are distinct pathways regulated by either App or
Aplp2. It remains unclear whether changes in expression of genes
in App and Aplp2 ko mice are due to direct transcriptional activity
of the intracellular domains of these proteins or to an indirect ef-
fect of loss of those proteins [39,57,58].
4. A role of App and Aplps in cortical development
The mammalian cortex has expanded rapidly across different
species and this is associated with the evolution of neocortical re-
lated behaviour such as perception and cognition [59]. The expan-
sion of the cortical surface is believed to underlie the transition
from a smooth cortex (lissencephalic) to a highly folded cortex
(gyrencephalic). Indeed, changes in the proliferative pattern of
ventricular zone resident neural stem cells have been titled as ‘‘a
giant leap for mankind’’ referring to the expanded surface of the
human cortex as a consequence of the more proliferative radial glia
cell units in the developing human brain [60]. Neural progenitors
outside the ventricular zone such as the intermediate progenitors
in the subventricular zone might be as well important contributors
to the evolutionary expansion of the cortex [59,61]. In mice, App
and Aplp2 are expressed in both ventricular and subventricular
neurogenic niches of the developing cortex, making these two pro-
teins interesting candidates for an important role in the develop-
ment and evolution of the cortex [54,62].
Two major neurogenic niches exist during cortical develop-
ment: the ventricular zone (VZ) largely populated by the radial glia
cells and the subventricular zone (SVZ) populated by intermediate
progenitors. More recently an additional class of progenitors called
Outer SVZ (OSVZ), populated by radial glia like cells that are not at-
tached to the ventricular zone, were described in human, ferret and
mouse [61,63,64]. Post-mitotic neurons born in those neurogenic
niches migrate towards the cortical plate (CP) using the ﬁbers pro-
vided by the radial glia cells. This mode of migration is called glia
guided migration. The glia guided migration stops at a cellular
layer populated by Cajal-Retzius (CR) cells. CR cells produce Reelin
which binds to apolipoprotein E receptor 2 (ApoER2) and Very lowdensity lipoprotein receptor (Vldlr) receptor to signal via disabled-
1 (Dab1) to control the end stage of neuronal migration by promot-
ing glia independent somal translocation [65,66]. Triple deletion of
App, Aplp1 and Aplp2 results in a reduced number of CR cells and
accumulation of neurons that over migrate to the marginal zones
of the developing cortex [7]. Likewise, deﬁciency of presenilin-1
decreases the number of CR cells and ectopic accumulation of neu-
rons in the marginal zones of the developing cortex [67], suggest-
ing the importance of c-secretase processing of APP or perhaps
other substrates in CR cell function. In contrast to this over-migra-
tion phenotype, Young-Pearse et al. [8] showed that single knock-
down of App in wild type mouse brain inhibited migration of
cortical neurons, while APP over-expression promoted the migra-
tion of neurons. The effects depended on the conserved YENPTY
in the carboxyl terminus. It is noteworthy that the endogenous
expression of Aplp1 and Aplp2 was not able to compensate for
the App shRNA effect, but co-electroporation of Aplp1 or Aplp2
could rescue the App deﬁcient migration phenotype indicating
that, when overexpressed, the proteins can be redundant. Thus
the regulation of expression levels of App and Aplps is critical for
their function [8]. Down-stream, Disc1 is an interactor of App with
key roles in neuronal progenitor proliferation and neuronal migra-
tion [68]. Over-expression of Disc1 can signiﬁcantly rescue the
migration effect observed after Dab1 or App down-regulation
[69]. Upstream, binding of different isoforms of pancortins mediate
different effects on processing of APP. Using an unbiased assay for
identiﬁcation of ectodomain binders of APP, Rice et al showed that
pancortins can bind to APP and that binding of pancortin isoform 1
and 2 (B-domain containing pancortins) can signiﬁcantly decrease
b-secretase processing of APP [70]. Down-regulation of pancortin 1
or over-expression of pancortin 4 resulted in similar migration de-
fects as observed after down-regulation of App in developing cor-
tex suggesting opposed roles for different isoforms of the
pancortins [70]. Expression of pancortin 1 or APP could rescue
the retarded migration of pancortin 4 over-expressing migratory
neurons [70]. Similar to pancortins, Reelin interacts with the extra-
cellular domain of APP in primary hippocampal neurons [71] and
Dab1 interacts with the highly conserved YENPTY motif in the
carboxyterminus of App. This interaction most likely depends on
the phosphorylation of tyrosine, highlighting further the impor-
tance of this residue for the developmental function of App pro-
teins [72]. Extracellular interaction of App with Reelin and
intracellular binding to Dab1 shows that App might work together
with ApoER2/Vldlr as (co)receptor to mediate the Reelin effect dur-
ing migration of neurons. Indeed, Dab1 over-expression could res-
cue the blocked migration induced by App shRNA in the developing
cortex. From these ﬁndings, a model emerges in which the ectodo-
main of App binds to Reelin or Pancortins at the cell surface, which
leads to signal transduction through down-stream effectors such as
Disc1 and Dab1 to regulate neuronal migration. It is very likely that
phosphorylation of the YENPTY motif at the c-terminus plays a
central role in this process. However, this model does not explain
the reduction of CR cells in triple ko mice [7], unless a cell auton-
omous effect of Reelin and App on for instance the survival of CR
cells is postulated.
It might be that Reelin has a dual site of action in the developing
cortex. For example, similar to what happens in the post-mitotic
migratory neurons, Reelin-Dab1 could directly signal to radial glial
cells regulating their morphology and rate of neurogenesis [73–75].
Therefore, it is likely that during cortical development App andAplp2
can regulate Reelin signalling in bothmigrating neurons andprolifer-
ating neural stem cells and, hypothetically, in CR cells. Moreover, the
YENPTYmotif is present in the App-like proteins raising the possibil-
ity that Reelin can also signal through Aplps to controlmigration and
differentiation of cortical precursor and progenitors.
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in App/Aplp1 dko neurons or dko neurons expressing Aplp2 shRNA
or triple ko neurons [55,76]. Instead, we showed that down-regu-
lation of Aplp2 in App/Aplp1 dko progenitors decreased cell cycle
exit and delayed differentiation of progenitors [55] which matched
very well with its expression proﬁle in the VZ/SVZ [54].
Regarding the discrepancy in the migration phenotypes caused
by alterations of App expression in different experimental para-
digms, it is possible that the genomic deletion of App and/or Aplp1
triggers adaptive responses that are not activated when App is
acutely knocked-down using shRNA. Altogether, the available ﬁnd-
ings suggest that the different App paralogues have both special-
ized and redundant functions in different sub-regions of the
developing cortex. Aplp2 is important in the regulation of differen-
tiating neuronal precursor cells, App in migratory neurons. Further
understanding of the roles of App and Aplps during cortical devel-
opment would emerge by identiﬁcation of their speciﬁc interaction
network in different sub-regions of the developing cortex.
Although the current model proposes App as a cell surface
(co)receptor, it is likely that soluble ectodomains of App and Aplps
work as ligands to regulate migration and differentiation in a non-
autonomous fashion. In ﬂies soluble APPL function non-autono-
mously to regulate the axonal outgrowth in developing mushroom
bodies. The developmental defect in outgrowth of a lobe axons in
mushroom bodies of applmutant ﬂies was rescued by soluble APPL
while b lobe defects were rescued only with full-length APPL, sug-
gesting a non-autonomous effect of soluble APPL on a lobe devel-
opment [29]. Moreover, it has been shown that sAPP can induce
proliferation of Egf positive neural stem cells in the lateral ventricle
suggesting the possibility of ligand-receptor model for sAPP func-
tion in neurogenesis [56]. Therefore, identiﬁcation of sAPP and
sAPLPs putative receptors would be a major step in understanding
the biology of App and Aplps.
5. Processing of the APP family is conserved over evolution
A common feature of APP and APP-like proteins is their process-
ing by membrane secretases [49,77–80]. The proteolytic process-
ing of APP have been studied in large detail (reviewed in [81]). In
addition to ectodomain shedding, this proteolytic processing of
APP results in the release of Ab. As this is a continuous process,
the brain faces constantly the challenging task of controlling the
concentration of Ab below the aggregation threshold. The Ab re-
gion is a novel feature of the APP paralogue and is not present in
APLP1&2 or in the APP-homologues in C. elegans (APL1) and D. mel-
anogaster (APPL). Interestingly, all the proteases involved in APP
processing, i.e., a-secretases, b-secretases and c-secretases are
conserved during evolution, together with the overall processing
of the membrane bound APP paralogues resulting in the release
of APP ectodomain and intracellular domain.
One C. elegans homologue of the catalytic subunit of c-secretase
or presenilin 1 (PS1) is called sel12 [23]. Another C. elegans homo-
logue of human presenilin is hop1which can compensate for loss of
sel12 phenotypes such as egg-laying defect [82]. In ﬂies, a 130KD
fragment that misses the carboxyl terminus of full-length APPL
was identiﬁed and proposed as a secreted form of APPL [25]. Kuz-
banian is the a secretase-like protease of ﬂies which was indenti-
ﬁed because of its role in regulation of Notch signaling and
neurogenesis [83]. More recently it was shown that Kuzbanian is
also involved in the processing of ﬂies’ APPL [84]. Likewise, b-
secretase activity has been described in ﬂies and surprisingly
dBACE can process APPL into a neurotoxic peptide which can de-
posit in the brain similar to human APP [84].
Similar to vertebrates, insect c-secretase is a multiprotein com-
plex whose activity depends on Presenilin. Takasugi et al. showedthat Drosophila presenilin can restore the c-secretase activity of
PS1/PS2 dko mouse ﬁbroblast and increase Ab production when ex-
pressed in N2A human cells [85]. In contrast to heterogeneous
mammalian c-secretase complexes [86,87], c-secretase in Dro-
sophila exists only in one composition because there is only one
gene for each subunit of c-secretase. In vivo reconstitution of Dro-
sophila c-secretase, showed that it can efﬁciently cleave Notch but
has poor activity towards APP and APLP2 suggesting substrate
speciﬁcity of the ancestral c-secretase [88]. Therefore, although
the cleavage activity of c-secretase is conserved, it seems that
the regulation of this activity has evolved in mammals by hetero-
geneity in composition of c-secretase.
The biochemical similarities and conservation of the process-
ing of APP and APP-like proteins supports the idea of functional
redundancy. In contrast, the end products of APP, APLP1 and
APLP2 processing differ in length and amino acid composition,
and perhaps acquire different structures. Compared with the
Ab peptide with its variable length between 37 and 43 amino
acids and its propensity to aggregate, sequential cleavage of
APLP1 by b and c secretases generates p28, an APLP1 b pep-
tide-like fragment, with 25–28 amino acids which does not
aggregate in the brain [89]. Interestingly, the analogy between
the processing of APP and APLP1 has raised the possibility of
using APLP1 derived p28 in the cerebrospinal ﬂuid as a surrogate
marker to detect altered activity of c secretases in individuals
with an increased risk of AD [89]. Processing of APLP2 appears
even more elaborate with several c-terminus fragments that
are variable in size [77]. Thus, APLP2 processing might release
fragments that are different in length, sequence and structure
compared to APP. Given these differences, it has been proposed
that processed products from the different APP paralogues might
regulate distinct signaling pathway, even though they experience
similar biochemical processing [80].
6. Transcriptional divergence of APP and APLPs imply
functional divergence
An important step in the evolution of gene duplicates is the
modiﬁcation of regulatory proximal elements leading to transcrip-
tional divergence. In turn, transcriptional divergence is likely to re-
sult in diversiﬁcation of the duplicates with regard to function.
Such genetic differences in regulatory elements of genes expressed
in the developing cortex has been proposed as a primary force driv-
ing the evolution of the brain [90,91].
In the genome of D. melanogaster and C. elegans, there is only
one APP-like gene. APl-1 of C. elegans is expressed in neurons as
well as a few other cell-types [23]. Expression of APPL in D. mela-
nogaster is restricted to the nervous system [92]. Similar to ﬂies
APPL, APLP1 shows a neuron speciﬁc expression in mammals
whereas APP and APLP2 are expressed by various cell types. Until
recently, APP was assumed to be expressed by all cell types in
the brain [62]. However, using a speciﬁc antibody to stain APP in
the adult brain, Guo et al showed that App is present predomi-
nantly in neurons in the adult brain [93]. At the transcript level,
a complementary expression pattern has emerged from in situ
analysis of App and Aplps transcripts. Lopez-Sanchez et al have
demonstrated that Aplp1 expression is restricted to the post-mito-
tic cortical plate and Aplp2 transcripts show a speciﬁc distribution
in proliferating ventricular/subventricular zone respectively. Inter-
estingly, App is expressed both in ventricular zone and post-mito-
tic neurons of the cortical plate showing partial overlapping
expression with Aplp1 and Aplp2 [54]. The same expression pat-
tern is observed in publicly available atlases of the developing cor-
tex including Genepaint and Eurexpress [94,95]. The region speciﬁc
expression pattern of App, Aplp1 and Aplp2 suggests functional
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development.
The genetic factors that contribute to the transcriptional diver-
gence of APP duplicates are not well deﬁned. However, analysis of
the proximal element of APP and APP-like genes in different species
reveal a CAGA box within the APP 50-UTR which is not present in
APP-like genes [96]. This CAGA box might regulate expression of
APP in response to inﬂammation linked signaling such as TGFb
[96]. More studies are needed to understand the contribution of
the proximal element that control regulated expression of APP
and APLPs. Even subtle changes in expression regulation of these
genes may account for distinct biological functions.
7. The interaction networks of APP, APLP1 and APLP2 show
speciﬁcity
Proteins are part of a dynamic network which show cell type
and tissue speciﬁcity [97]. Evolutionary changes in speciﬁcity
and strength of these interactions impact the function of the pro-
teins and their networks [98]. Rewiring of the interaction network
of paralogous proteins is a clear sign for their functional divergence
[98].
Several binding partners have been proposed for APP with var-
ious functional implications. (For review see [16,38,99]). In general,
the interactors of APP can be divided into those that bind at the
extracellular side with a possible ligand mode of action and those(A)
(C)
Fig. 2. (A) Phylogenetic tree of APP protein family with three clusters of APP homologue
APL-1 cluster separately. (B) Functional distance analysis of phylogenetic tree of APP pro
compared to APP and APLP1. The diagram illustrates the degree of the divergence of each
speciation. (C) The heatmap of (site-speciﬁc) shifted evolutionary rate from n-terminus (
APLP1 are least divergent. The data is derived based on Gu Statistical method (Diverge2
APLP2.that bind at the intracellular side with a possible signaling mode of
action. F-spondin, Tag1, Reelin, Netrin, Lingo-1, Pancortins are
some examples of extra-cellular binding proteins while Fe65, JIP,
JNK, Mint1/X11, Dab1 are among intracellular binding proteins to
APP [16,70,99]. If APP and APLPs share similar biological function,
then they are expected to be part of similar protein networks.
However, a study by Bai et al challenges this idea [100]. A signiﬁ-
cant proportion of identiﬁed APP interactors in their study were
consistent with previously published data supporting the reliabil-
ity of their analysis. Surprisingly therefore, comparing the interac-
tors of the three paralogues showed only one interactor in
common: Ras GAP-activating like Protein 1 that binds to both
APLP1 and APLP2 [100]. Over-representation of ER chaperones in
the APP interaction network might suggest sensitivity of APP fold-
ing, while APLP2 interacted distinctly with the Rho family of GTP-
ases such as RhoA and RAC1 [100].
It is likely that the difference in the interaction networks of APP
and APLPs reﬂects their differential subcellular localization and dif-
ferent tissue expression pattern. [101,102]. Indeed, using ﬂuores-
cent tagged version of APP and APLPs in HEK293 cells, Kaden
et al showed that APLP1-YFP is primarily localized to the cell sur-
face. Most of the APP-YFP was found however in intracellular com-
partments such as the ER and endosomes and to a lesser extent the
Golgi apparatus. APLP2 was equally distributed at the cell surface
and intracellular compartments showing partial overlapping local-
ization with both APP and APLP1 [102].(B)
s in different species highlighted in different colors. Notice that ﬂy APPL and worm
tein family shows that APLP2 is more distant from an inferred ancestral gene when
cluster based on (site-speciﬁc) shifted evolutionary rates after gene duplication or
left) to c-terminus shows that APLP1 and APLP2 are the most divergent and APP and
software). Notice that many of the shifted sites are in the extracellular domain of
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Conservation of an amino acid residue in a sequence correlates
with functional importance [103–105]. In brief, three possibilities
exist for evolution of each residue of gene A and its duplicate B:
1) super conservation throughout the gene family (Type 0 evolu-
tion). A nice example of Type 0 evolution is the YENPTY motif at
the carboxyl terminal of the APP family that is universally con-
served (Fig. 3). Conserved in gene A and variable in the B duplicate
(Type I evolution) 3) Conserved in both A and B but having differ-
ent biochemical properties (Type II evolution) [104]. To test our
hypothesis on functional divergence of APP and APLP, we used
the statistical method developed by Gu in 1999 [105]. In this meth-
od, the altered functional constraint is estimated by calculating
site-speciﬁc rate differences between duplicates.
We aligned the APP and APLPs sequences from nine species (24
genes, Table 1) to generate the phylogenetic tree of the APP family.
using Neighbor-Joining Tree making of Diverge 2 software devel-
oped by Gu [103]. After rerooting separate cluster of APPL and
APL1, the tree revealed three distinct clusters for APP, APLP1, and
APLP2 (Fig. 2A). Scanning the amino acid residues of the APP and
APLP1 cluster did not reveal any sites that might signiﬁcantly con-
tribute to functional constraint alteration (Fig. 2C). The coefﬁcient
of type I functional divergence (h) between the APP cluster and the
APLP1 cluster is very low (0.10) suggesting functional conservation
of APP and APLP1. Thus, structurally the two types of proteins are
quite related and mainly transcriptional divergence has to be con-
sideredwhen evaluating speciﬁcation of APLP1 function. Consistent
with the data from the animal models, APLP2 shows signiﬁcant
divergence frombothAPPandAPLP1with coefﬁcients of type I func-
tional divergence of 0.29 for APP-APLP2 and 0.53 for APLP1-APLP2
(Fig. 2B). Using Diverge 2 software, we identiﬁed several residuesFig. 3. An example of the speciﬁc APLP2 motif at the N terminus contributing to its
divergence. Alignment of different cluster shows that GTGFAVAE motif at the N-
Terminus is speciﬁc to APLP2 and opposite of this motif is super conserved YENPTY
at the C-terminus.of APLP2 that contributed to its functional divergence from APP
and APLP1 (Fig. 2B, C). Many of those residues are located in the
extracellular domain of APLP2 (Fig. 2C) suggesting a speciﬁc role
for this domain. Of note, the GTGFAVAEmotif at the very N terminal
APLP2 cluster, is not found in the APP and APLP1 cluster (Fig. 3).
Experimental data will be valuable in understanding how those res-
idues confer speciﬁc function. These ﬁndings are consistent with a
model in which APLP2 is differentiated from APP and APLP1 by
changing its extracellular fragment while the carboxyl terminus re-
mains largely conserved between all three APP family members.
9. Concluding remarks
The evolutionary tree of APP proteins reﬂects a complex trajec-
tory which cannot be simpliﬁed into the ‘‘redundancy’’ or ‘’diver-
gence’’ model. Clearly, some functions of the family are
preserved; especially the neuron speciﬁc functions at the synapse
appear to fall under this category. However, also innovation has
happened in this gene family leading to divergence of their expres-
sion and interaction networks. Further efforts to understand these
speciﬁc features of each family member could address some of the
following open questions.
1. What are the critical amino acid and motifs conferring speciﬁc
features to each duplicate? Mutagenesis of the divergent motifs
would be valuable in understanding the speciﬁc feature of each
member [106].
2. How did cis-regulatory sequences of APP and APLPs diverge and
how does this compare to the amino acid coding sequences?
3. Finally, the most challenging topic is to understand the special-
ized functions of each member which, by deﬁnition, should not
be complemented by the other APP members.
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